TrialJournal for immunotherapy of cancer2021

Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer.

Meenal Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.